<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22956971</PMID><DateCompleted><Year>2012</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1740-2530</ISSN><JournalIssue CitedMedium="Internet"><Volume>2012</Volume><PubDate><Year>2012</Year></PubDate></JournalIssue><Title>Clinical &amp; developmental immunology</Title><ISOAbbreviation>Clin Dev Immunol</ISOAbbreviation></Journal><ArticleTitle>Cytokine immunopathogenesis of enterovirus 71 brain stem encephalitis.</ArticleTitle><Pagination><StartPage>876241</StartPage><MedlinePgn>876241</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">876241</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2012/876241</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) is one of the most important causes of herpangina and hand, foot, and mouth disease. It can also cause severe complications of the central nervous system (CNS). Brain stem encephalitis with pulmonary edema is the severe complication that can lead to death. EV71 replicates in leukocytes, endothelial cells, and dendritic cells resulting in the production of immune and inflammatory mediators that shape innate and acquired immune responses and the complications of disease. Cytokines, as a part of innate immunity, favor the development of antiviral and Th1 immune responses. Cytokines and chemokines play an important role in the pathogenesis EV71 brain stem encephalitis. Both the CNS and the systemic inflammatory responses to infection play important, but distinctly different, roles in the pathogenesis of EV71 pulmonary edema. Administration of intravenous immunoglobulin and milrinone, a phosphodiesterase inhibitor, has been shown to modulate inflammation, to reduce sympathetic overactivity, and to improve survival in patients with EV71 autonomic nervous system dysregulation and pulmonary edema.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shih-Min</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 70428, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Huan-Yao</ForeName><Initials>HY</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ching-Chuan</ForeName><Initials>CC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Egypt</Country><MedlineTA>Clin Dev Immunol</MedlineTA><NlmUniqueID>101183692</NlmUniqueID><ISSNLinking>1740-2522</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016756">Immunoglobulins, Intravenous</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001933" MajorTopicYN="N">Brain Stem</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018792" MajorTopicYN="N">Encephalitis, Viral</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016756" MajorTopicYN="N">Immunoglobulins, Intravenous</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056747" MajorTopicYN="N">Immunomodulation</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2012</Year><Month>8</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22956971</ArticleId><ArticleId IdType="pmc">PMC3432373</ArticleId><ArticleId IdType="doi">10.1155/2012/876241</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dinarello CA. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest. 1997;112(6, supplement):321S&#x2013;329S.</Citation><ArticleIdList><ArticleId IdType="pubmed">9400897</ArticleId></ArticleIdList></Reference><Reference><Citation>Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda KI, Nakamua M. Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis. Cytokine. 2005;29(4):169&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">15652449</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lu IH, Lin YL, et al. The severity of Streptococcus pyogenes infections in children is significantly associated with plasma levels of inflammatory cytokines. Diagnostic Microbiology and Infectious Disease. 2008;61(2):165&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pubmed">18296003</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakane A, Okamoto M, Asano M, Kohanawa M, Minagawa T. Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice. Infection and Immunity. 1995;63(4):1165&#x2013;1172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC173129</ArticleId><ArticleId IdType="pubmed">7890367</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameron MJ, Bermejo-Martin JF, Danesh A, Muller MP, Kelvin DJ. Human immunopathogenesis of severe acute respiratory syndrome (SARS) Virus Research. 2008;133(1):13&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7114310</ArticleId><ArticleId IdType="pubmed">17374415</ArticleId></ArticleIdList></Reference><Reference><Citation>Skoner DP, Gentile DA, Patel A, Doyle WJ. Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus. Journal of Infectious Diseases. 1999;180(1):10&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">10353855</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei HY, Yeh TM, Liu HS, Lin YS, Chen SH, Liu CC. Immunopathogenesis of dengue virus infection. Journal of Biomedical Science. 2001;8(5):377&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pubmed">11549879</ArticleId></ArticleIdList></Reference><Reference><Citation>Su IJ. Perspectives on the pathogenesis and therapy of hemophagocytic syndrome. Journal of the Formosan Medical Association. 2008;107(4):277&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">18445540</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiology Reviews. 2002;26(1):91&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiung GD, Wang JR. Enterovirus infections with special reference to enterovirus 71. Journal of Microbiology, Immunology and Infection. 2000;33(1):1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10806956</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Liu CC, Tseng HW, et al. Clinical spectrum of enterovirus 71 infection in children in Southern Taiwan, with an emphasis on neurological complications. Clinical Infectious Diseases. 1999;29(1):184&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">10433583</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M, Chen ER, Hsu KH, et al. An epidemic of enterovirus 71 infection in Taiwan. The New England Journal of Medicine. 1999;341(13):929&#x2013;935.</Citation><ArticleIdList><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF. Neurologic complications in children with enterovirus 71 infection. The New England Journal of Medicine. 1999;341(13):936&#x2013;942.</Citation><ArticleIdList><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin TY, Chang LY, Hsia SH, et al. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clinical Infectious Diseases. 2002;34(supplement 2):S52&#x2013;S57.</Citation><ArticleIdList><ArticleId IdType="pubmed">11938497</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Ho TS, Shen CF, Liu CC. Enterovirus 71, one virus and many stories. Pediatrics and Neonatology. 2008;49(4):113&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pubmed">19054915</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Liu CC. Enterovirus 71: epidemiology, pathogenesis and management. Expert Review of Anti-Infective Therapy. 2009;7(6):735&#x2013;742.</Citation><ArticleIdList><ArticleId IdType="pubmed">19681701</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin TY, Chang LY, Huang YC, Hsu KH, Chiu CH, Yang KD. Different proinflammatory reactions in fatal and non-fatal enterovirus 71 infections: implications for early recognition and therapy. Acta Paediatrica. 2002;91(6):632&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pubmed">12162592</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Lin TY, Hsu KH, et al. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. The Lancet. 1999;354(9191):1682&#x2013;1686.</Citation><ArticleIdList><ArticleId IdType="pubmed">10568570</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lei HY, Huang KJ, et al. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. Journal of Infectious Diseases. 2003;188(4):564&#x2013;570.</Citation><ArticleIdList><ArticleId IdType="pubmed">12898444</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin TY, Hsia SH, Huang YC, Wu CT, Chang LY. Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clinical Infectious Diseases. 2003;36(3):269&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pubmed">12539066</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lei HY, Su LY, et al. Cerebrospinal fluid cytokines in enterovirus 71 brain stem encephalitis and echovirus meningitis infections of varying severity. Clinical Microbiology and Infection. 2007;13(7):677&#x2013;682.</Citation><ArticleIdList><ArticleId IdType="pubmed">17441979</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lei HY, Yu CK, Wang JR, Su IJ, Liu CC. Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis. Journal of Infectious Diseases. 2008;198(7):1002&#x2013;1006.</Citation><ArticleIdList><ArticleId IdType="pubmed">18710325</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Ho TS, Lin HC, Lei HY, Wang JR, Liu CC. Reemerging of enterovirus 71 in Taiwan: the age impacton disease severity. EuropeanJournal of Clinical Microbiology and Infectious Diseases. 2012;31(6):1219&#x2013;1224.</Citation><ArticleIdList><ArticleId IdType="pubmed">21983920</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao SJ, Yang FL, Ksu YH, Chen HI. Mechanism of fulminant pulmonary edema caused by enterovirus 71. Clinical Infectious Diseases. 2004;38(12):1784&#x2013;1788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7107954</ArticleId><ArticleId IdType="pubmed">15227628</ArticleId></ArticleIdList></Reference><Reference><Citation>Hask&#xf3; G. Receptor-mediated interaction between the sympathetic nervous system and immune system in inflammation. Neurochemical Research. 2001;26(8-9):1039&#x2013;1044.</Citation><ArticleIdList><ArticleId IdType="pubmed">11699931</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nature Medicine. 2009;15(7):794&#x2013;797.</Citation><ArticleIdList><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel KP, Bergelson JM. Receptors identified for hand, foot and mouth virus. Nature Medicine. 2009;15(7):728&#x2013;729.</Citation><ArticleIdList><ArticleId IdType="pubmed">19584857</ArticleId></ArticleIdList></Reference><Reference><Citation>Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Advances in Immunology. 1993;54:1&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">8379461</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lei HY, Huang MC, et al. Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis. Journal of Clinical Virology. 2006;37(1):47&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">16861032</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YW, Wang SW, Tung YY, Chen SH. Enterovirus 71 infection of human dendritic cells. Experimental Biology and Medicine. 2009;234(10):1166&#x2013;1173.</Citation><ArticleIdList><ArticleId IdType="pubmed">19596831</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong WX, Foo DGW, Trasti SL, Tan EL, Alonso S. Sustained high levels of interleukin-6 contribute to the pathogenesis of enterovirus 71 in a neonate mouse model. Journal of Virology. 2011;85(7):3067&#x2013;3076.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3067852</ArticleId><ArticleId IdType="pubmed">21228224</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore KW, de Waal Malefyt R, Coffman RL, O&#x2019;Garra A. Interleukin-10 and the interleukin-10 receptor. Annual Review of Immunology. 2001;19:683&#x2013;765.</Citation><ArticleIdList><ArticleId IdType="pubmed">11244051</ArticleId></ArticleIdList></Reference><Reference><Citation>Grilli M, Barbieri I, Basudev H, et al. Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage. European Journal of Neuroscience. 2000;12(7):2265&#x2013;2272.</Citation><ArticleIdList><ArticleId IdType="pubmed">10947805</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-&#x3b3; . Annual Review of Immunology. 1997;15:749&#x2013;795.</Citation><ArticleIdList><ArticleId IdType="pubmed">9143706</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin S, Maruta K, Burkart V, Gillis S, Kolb H. IL-1 and IFN-&#x3b3; increase vascular permeability. Immunology. 1988;64(2):301&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1384958</ArticleId><ArticleId IdType="pubmed">3134297</ArticleId></ArticleIdList></Reference><Reference><Citation>Corada M, Mariotti M, Thurston G, et al. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proceedings of the National Academy of Sciences of the United States of America. 1999;96(17):9815&#x2013;9820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC22293</ArticleId><ArticleId IdType="pubmed">10449777</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong WX, Yan B, Yeo H, et al. A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. Journal of Virology. 2012;86(4):2121&#x2013;2131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302383</ArticleId><ArticleId IdType="pubmed">22130542</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuel CE. Antiviral actions of interferons. Clinical Microbiology Reviews. 2001;14(4):778&#x2013;809.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC89003</ArticleId><ArticleId IdType="pubmed">11585785</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu ML, Lee YP, Wang YF, et al. Type I interferons protect mice against enterovirus 71 infection. Journal of General Virology. 2005;86(12):3263&#x2013;3269.</Citation><ArticleIdList><ArticleId IdType="pubmed">16298971</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vries JE. The role of IL-13 and its receptor in allergy and inflammatory responses. Journal of Allergy and Clinical Immunology. 1998;102(2):165&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pubmed">9723655</ArticleId></ArticleIdList></Reference><Reference><Citation>Brightling CE, Saha S, Hollins F. Interleukin-13: prospects for new treatments. Clinical and Experimental Allergy. 2010;40(1):42&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3992377</ArticleId><ArticleId IdType="pubmed">19878194</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunological Reviews. 2004;202:175&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">15546393</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SW, Lee YP, Hung YT, et al. Exogenous interleukin-6, interleukin-13, and interferon-gamma provoke pulmonary abnormality with mild edema in enterovirus 71-infected mice. Respiratory Research. 2011;12(1, article 147)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3223501</ArticleId><ArticleId IdType="pubmed">22054060</ArticleId></ArticleIdList></Reference><Reference><Citation>Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annual Review of Immunology. 2004;22:891&#x2013;928.</Citation><ArticleIdList><ArticleId IdType="pubmed">15032599</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunkel SL, Standiford T, Kasahara K, Strieter RM. Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Experimental Lung Research. 1991;17(1):17&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">2013270</ArticleId></ArticleIdList></Reference><Reference><Citation>Talavera D, Castillo AM, Dominguez MC, Gutierrez AE, Meza I. IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. Journal of General Virology. 2004;85(7):1801&#x2013;1813.</Citation><ArticleIdList><ArticleId IdType="pubmed">15218164</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekido N, Mukaida N, Harada A, Nakanishi I, Watanabe Y, Matsushima K. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature. 1993;365(6447):654&#x2013;657.</Citation><ArticleIdList><ArticleId IdType="pubmed">8413628</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao Z, Ye Q, Gong W, Xiang Y, Wan H. Humanized monoclonal antibody against the chemokine CXCL-8 (IL-8) effectively prevents acute lung injury. International Immunopharmacology. 2010;10(2):259&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pubmed">19909826</ArticleId></ArticleIdList></Reference><Reference><Citation>Puneet P, Moochhala S, Bhatia M. Chemokines in acute respiratory distress syndrome. American Journal of Physiology&#x2014;Lung Cellular and Molecular Physiology. 2005;288(1):L3&#x2013;L15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7191630</ArticleId><ArticleId IdType="pubmed">15591040</ArticleId></ArticleIdList></Reference><Reference><Citation>Salazar-Mather TP, Hamilton TA, Biron CA. A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. Journal of Clinical Investigation. 2000;105(7):985&#x2013;993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC377490</ArticleId><ArticleId IdType="pubmed">10749577</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato M, Hosoya M, Honzumi K, et al. Cytokine and cellular inflammatory sequence in enteroviral meningitis. Pediatrics. 2003;112(5):1103&#x2013;1107.</Citation><ArticleIdList><ArticleId IdType="pubmed">14595053</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson T, Kelic S, Edlund C, et al. Neuronal interferon-&#x3b3; immunoreactive molecule: bioactivities and purification. European Journal of Immunology. 1994;24(2):308&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pubmed">8299680</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosoi T, Okuma Y, Nomura Y. Electrical stimulation of afferent vagus nerve induces IL-1&#x3b2; expression in the brain and activates HPA axis. American Journal of Physiology&#x2014;Regulatory Integrative and Comparative Physiology. 2000;279(1):R141&#x2013;R147.</Citation><ArticleIdList><ArticleId IdType="pubmed">10896875</ArticleId></ArticleIdList></Reference><Reference><Citation>Borsody MK, Weiss JM. Alteration of locus coeruleus neuronal activity by interleukin-1 and the involvement of endogenous corticotropin-releasing hormone. NeuroImmunoModulation. 2002;10(2):101&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pubmed">12372984</ArticleId></ArticleIdList></Reference><Reference><Citation>Lahrtz F, Piali L, Spanaus KS, Seebach J, Fontana A. Chemokines and chemotaxis of leukocytes in infectious meningitis. Journal of Neuroimmunology. 1998;85(1):33&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">9626995</ArticleId></ArticleIdList></Reference><Reference><Citation>Asensio VC, Campbell IL. Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis. Journal of Virology. 1997;71(10):7832&#x2013;7840.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192138</ArticleId><ArticleId IdType="pubmed">9311871</ArticleId></ArticleIdList></Reference><Reference><Citation>Huffman LM, Fife BT, Begolka WS, Miller SD, Karpus WJ. Central nervous system chemokine expression during Theiler&#x2019;s virus-induced demyelinating disease. Journal of NeuroVirology. 1999;5(6):635&#x2013;642.</Citation><ArticleIdList><ArticleId IdType="pubmed">10602404</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghersa P, Gelati M, Colinge J, et al. MIG&#x2014;differential gene expression in mouse brain endothelial cells. NeuroReport. 2002;13(1):9&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">11924901</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter SL, M&#xfc;ller M, Manders PM, Campbell IL. Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-&#x3b3; but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro. Glia. 2007;55(16):1728&#x2013;1739.</Citation><ArticleIdList><ArticleId IdType="pubmed">17902170</ArticleId></ArticleIdList></Reference><Reference><Citation>Elovaara I, Hietaharju A. Can we face the challenge of expanding use of intravenous immunoglobulin in neurology? Acta Neurologica Scandinavica. 2010;122(5):309&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">20085560</ArticleId></ArticleIdList></Reference><Reference><Citation>Abzug MJ, Keyserling HL, Lee ML, Levin MJ, Rotbart HA. Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin. Clinical Infectious Diseases. 1995;20(5):1201&#x2013;1206.</Citation><ArticleIdList><ArticleId IdType="pubmed">7620000</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishimoto C, Takamatsu N, Kawamata H, Shinohara H, Ochiai H. Immunoglobulin treatment ameliorates murine myocarditis associated with reduction of neurohumoral activity and improvement of extracellular matrix change. Journal of the American College of Cardiology. 2000;36(6):1979&#x2013;1984.</Citation><ArticleIdList><ArticleId IdType="pubmed">11092674</ArticleId></ArticleIdList></Reference><Reference><Citation>Shipley JB, Tolman D, Hastillo A, Hess ML. Milrinone: basic and clinical pharmacology and acute and chronic management. American Journal of the Medical Sciences. 1996;311(6):286&#x2013;291.</Citation><ArticleIdList><ArticleId IdType="pubmed">8659556</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashida N, Tomoeda H, Oda T, et al. Inhibitory effect of milrinone on cytokine production after cardiopulmonary bypass. Annals of Thoracic Surgery. 1999;68(5):1661&#x2013;1667.</Citation><ArticleIdList><ArticleId IdType="pubmed">10585039</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lei HY, Huang MC, et al. Therapeutic efficacy of milrinone in the management of enterovirus 71-induced pulmonary edema. Pediatric Pulmonology. 2005;39(3):219&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">15635619</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Venkataraman R. Blood purification in sepsis: an idea whose time has come? Critical Care Medicine. 2002;30(6):1387&#x2013;1388.</Citation><ArticleIdList><ArticleId IdType="pubmed">12072702</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinford RD, Baid S, Pascual M. Dialysis membrane adsorption during CRRT. American Journal of Kidney Diseases. 1997;30(5, supplement 4):S32&#x2013;S37.</Citation><ArticleIdList><ArticleId IdType="pubmed">9372977</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>